Akoya Biosciences Inc (AKYA)
2.62
-0.11
(-4.03%)
USD |
NASDAQ |
Nov 04, 16:00
2.62
0.00 (0.00%)
After-Hours: 20:00
Akoya Biosciences Debt to Equity Ratio: 3.402 for June 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2024 | 3.402 |
| March 31, 2024 | 2.306 |
| December 31, 2023 | 1.400 |
| September 30, 2023 | 1.030 |
| June 30, 2023 | 0.8851 |
| March 31, 2023 | 1.506 |
| December 31, 2022 | 1.080 |
| September 30, 2022 | 0.702 |
| Date | Value |
|---|---|
| June 30, 2022 | 0.4685 |
| March 31, 2022 | 0.3057 |
| December 31, 2021 | 0.2676 |
| September 30, 2021 | 0.2356 |
| June 30, 2021 | 0.2182 |
| March 31, 2021 | -0.5771 |
| December 31, 2020 | -0.6765 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-0.6765
Minimum
Dec 2020
3.402
Maximum
Jun 2024
0.8369
Average
0.702
Median
Sep 2022
Debt to Equity Ratio Benchmarks
| Bruker Corp | 1.206 |
| Azenta Inc | 0.00 |
| Harvard Bioscience Inc | 0.5306 |
| Bionano Genomics Inc | 0.241 |
| Singular Genomics Systems Inc | 0.0461 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 143.74M |
| Total Liabilities (Quarterly) | 121.50M |
| Shareholders Equity (Quarterly) | 22.25M |
| Current Ratio | 2.734 |
| Net Debt Paydown Yield | -2.11% |